Filing Flows › Journey Medical (DERM) › Emrosi revenue
Journey Medical (DERM) Emrosi revenue by quarter
Journey Medical's Emrosi revenue was $8.1M in Q2 2026 (second quarter 2026), +29% from Q1 2026. Over the last 6 quarters it ranged from $2.1M (Q1 2025) to $8.1M (Q2 2026).
| Quarter | Emrosi revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $8.1M | +29% | +189% |
| Q1 2026 | $6.3M | +25% | +202% |
| Q4 2025 | $5.0M | +2% | — |
| Q3 2025 | $4.9M | +75% | — |
| Q2 2025 | $2.8M | +35% | — |
| Q1 2025 | $2.1M | — | — |
Q2 2026 at a glance
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Journey Medical's Emrosi revenue?
Journey Medical's Emrosi revenue was $8.1M in Q2 2026 (second quarter 2026), +29% from Q1 2026.
How has Journey Medical's Emrosi revenue changed?
Over the last 6 quarters it ranged from $2.1M (Q1 2025) to $8.1M (Q2 2026).